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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2014, TaiwanBackground: Controversy exists about the relationship between maternal inflammation and
the development of different morbidities and mortality in the newborn. We aimed to establish
the incidence of clinical chorioamnionitis in our Neonatal Intensive Care Unit and its relation to
morbidity and mortality among very-low-birth-weight infants.
Methods: This was an observational study of a cohort of very-low-birth-weight neonates
admitted to our Neonatal Intensive Care Unit, between January 2008 and December 2012. De-
mographic characteristics and outcomes were analyzed and a comparison between exposed
and non-exposed infants was carried out.
Results: During the study period, 451 very-low-birth-weight infants were admitted
to our Neonatal Intensive Care Unit, and 31 (6.87%) were exposed to maternal clinical chor-
ioamnionitis. The incidence was higher at lower gestational ages: 13.2% (23e26 weeks),
8.1% (27e30 weeks), and 2.6% (31e34 weeks) (p Z 0.022). After correcting by gestational
age and birth weight, early-onset neonatal sepsis (adjusted relative risk Z 6.13; 95% confi-
dence intervalZ 1.67e22.58; pZ 0.006) and periventricular leukomalacia (adjusted relative
riskZ 24.62; 95% confidence intervalZ 1.87e324.28; pZ 0.015) were significantly associated
with maternal clinical chorioamnionitis. There were no differences in mortality or in survival
without major morbidity.
Conclusion: Clinical chorioamnionitis confers an increased risk of early-onset neonatal sepsis
and periventricular leukomalacia to exposed very-low-birth-weight infants.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.iversitario Materno Infantil de Las Palmas, Avenida Marı´tima del Sur, S/N, 35016 Las Palmas de Gran
om (F. Garcı´a-Mun˜oz Rodrigo).
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Figure 1 Incidence of clinical chorioamnionitis according to
gestational age.Chorioamnionitis is an intrauterine inflammatory condition,
mainly caused by bacterial invasion of the amniochorionic
membranes. It can lead to a fetal inflammatory response
that contributes to multi-organ injury, and it is frequently
involved in the origin of the preterm premature rupture of
membranes and spontaneous preterm birth, especially at
the earliest gestational ages (GAs).1,2
Frequently the inflammation is subclinical, but histo-
logical, biochemical, or microbiological findings can be
present. The clinical diagnosis is usually based on the
presence of maternal fever, maternal or fetal tachycardia,
uterine tenderness, foul smelling vaginal discharge, and
maternal leucocytosis or elevated C-reactive protein, but
the criteria vary among studies.
Chorioamnionitis has been considered a risk factor for
neonatal sepsis, respiratory distress syndrome (RDS),
bronchopulmonary dysplasia (BPD), intraventricular hem-
orrhage (IVH), periventricular leukomalacia (PVL), cerebral
palsy, retinopathy of prematurity (ROP), and develop-
mental delay.3,4 However, it was reported some years ago
that histological but not clinical chorioamnionitis decreases
the incidence and severity of RDS, although it may increase
the susceptibility to BPD.5 Recent studies, however, seem
to confirm the effect of chorioamnionitis on the incidence
of RDS, but no effects on BPD are appreciated.6 Further-
more, some studies could not demonstrate any association
with these morbidities or with mortality, mainly after
adjusting by GA.4,7,8 Differences in definitions and inclusion
criteria, together with changes in clinical practice, could
be the reasons for such discrepancies, and controversy still
persists. Other important methodological problems of pre-
vious studies were retrospective design, and the lack of
power to detect confounder factors that could alter the
relationship between clinical chorioamnionitis and
neonatal outcomes.
Therefore, we conducted a prospective study with the
objective to determine the incidence of clinical cho-
rioamnionitis in our population, its association with GA at
birth, and its effects on neonatal morbidity and mortality in
a large cohort of very-low-birth-weight (VLBW) infants.
2. Methods
This was an observational, prospective study of a cohort of
VLBW neonates who were born in our maternity and/or
admitted to our Neonatal Intensive Care Unit in the first
28 days of life, between January 2008 and December 2012.
We included all consecutive newborn infants with a birth
weight 1500 g and/or <30 weeks of gestational age. Data
were collected systematically according to a pre-
established protocol until death or discharge from hospi-
tal. All records were supervised by one investigator (F.G.-
M.R.). The study protocol was approved by the Institutional
Review Board.
Clinical chorioamnionitis was defined according to
adapted Gibbs criteria,9 as maternal fever 38C at least
on two occasions separated by 1 hour, plus as least two of
the following: uterine tenderness defined as pain referred
by the mother on abdomen palpation in the absence ofuterine contractions, leucocytosis (>15,000 cells/mm3),
maternal tachycardia (>100 bpm), fetal tachycardia
(>160 bpm), or foul smelling vaginal discharge.
GA was established according to the best available ob-
stetric estimation, taking into account the maternal last
menstrual period, obstetrical parameters, and an early
prenatal ultrasound. If necessary, GA was also assessed by
the attending neonatologist on the basis of physical criteria
and/or neurological examination (new Ballard score).10 GA
was recorded in completed weeks.
Maternal and neonatal demographic data were
collected, including maternal age, parity, prenatal care and
morbidities (diabetes, hypertension, etc.), multiple or
single gestation, antenatal steroids and antibiotics admin-
istration, type of delivery and resuscitation, GA, birth
weight, sex, Apgar score at 1 minute and 5 minutes, and
admission temperature.
Neonatal morbidity was compared between exposed and
non-exposed infants, including the following: RDS (defined
by the presence of respiratory symptoms, the need of ox-
ygen or invasive or non-invasive mechanical ventilation,
and a compatible chest X-ray in the first 24 hours), patent
ductus arteriosus (PDA) detected by ultrasonography, early-
onset neonatal sepsis (EONS) and late-onset neonatal sepsis
(LONS; bacterial infection documented by a positive blood
culture in the first 72 hours or after that, respectively),
necrotizing enterocolitis (NEC) defined according to Bell’s
criteria (stage 2),11 severe IVH (defined as Grades 3 and 4
by Papile et al12), PVL, BPD (dependency of oxygen sup-
plementation at 36 weeks’ postmenstrual age), and ROP
(>2 stage). We also analyzed and compared total length of
stay, survival, and survival without major morbidity (major
morbidity includes any of the following: severe IVH, PVL,
BPD, NEC, or ROP >2 stage).
2.1. Data analysis
Statistical analyses were performed with SPSS-19 software
(SPSS Inc., Chicago, IL, USA). Normality of data was
assessed with the KolmogoroveSmirnov test. Centralization
measures are expressed as mean and standard deviation
(SD). Mean comparisons between groups were performed
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tistically significant. Qualitative variables were expressed
as proportion (%) and for statistical analysis the c2 test or
the Fisher exact test was used. Linear and logistic regres-
sion analyses were conducted to estimate the outcomes
adjusted by GA and BW. Relative risk (RR) and 95% confi-
dence interval (95% CI) were computed for outcomes. All
the hypotheses were two-tailed tested, and p < 0.05 was
considered statistically significant.
3. Results
During the study period, 451 VLBW newborns were admitted
to our Neonatal Intensive Care Unit, with the following GA
distribution: 68 (23e26 weeks), 232 (27e30 weeks), 151
(31e34 weeks), and 9 (35 weeks). In 31 cases (6.9%), the
mother had a diagnosis of clinical chorioamnionitis, which
was significantly higher with decreasing GA (p Z 0.022;
Figure 1). The main characteristics and findings at birth of
exposed and non-exposed infants are summarized in
Table 1. In general, infants in the chorioamnionitis group
had significantly lower GA, BW, and Apgar scores at 1 min-
ute, needing more frequently advanced cardiopulmonary
resuscitation (CPR). There were no differences in sex,Table 1 Baseline perinatal characteristics of neonates
with and without exposure to maternal clinical
chorioamnionitis.
Characteristics Clinical
chorioamnionitis
(n Z 31)
Absence of
maternal
chorioamnionitis
(n Z 420)
p
Gestational
age (wk)
27.9 (2.3) 29.6 (2.7) 0.001
Birth weight (g) 1029.7 (232.9) 1144.0 (253.7) 0.015
Male sex 48.4 54.0 0.542
Cesarean
delivery
54.8 57.1 0.803
Antenatal
steroids
90.3 87.7 0.671
One dose 19.3 20.2
Two doses 70.9 67.4
Maternal
hypertension
17.2 24.4 0.382
Maternal
antibiotics
90.3 39.0 <0.05
Multiple
gestations
19.4 27.1 0.344
Apgar score at
1 min <7
61.3 42.4 0.041
Apgar score at
5 min <7
12.9 9.0 0.476
Advanced CPR* 48.4 22.9 0.001
Admission
temperature
36.1 (0.54) 35.8 (0.62) 0.051
Data are presented as mean (SD) or %.
* Advanced cardiopulmonary resuscitation included endotra-
cheal intubation, chest compressions, and/or the administra-
tion of medications.cesarean delivery, antenatal steroids, maternal hyperten-
sion, or rate of multiple gestations between the two groups
(Table 1). After adjusting by GA and BW, the differences in
postnatal depression and in the need of advanced CPR
disappeared: the adjusted relative risk (ARR) for 1 minute
Apgar score <7 was 1.574 (95% CI Z 0.724e3.420;
p Z 0.052), and for advanced CPR it was 2.048 (95%
CI Z 0.899e4.715; p Z 0.092).
Table 2 shows the incidence of morbidity and mortality
between infants exposed and not exposed to maternal
clinical chorioamnionitis. RDS, EONS, and cystic periven-
tricular leukomalacia (cPVL) were significantly more
frequent in the exposed group. Surfactant was adminis-
tered to 14 infants in the chorioamnionitis group (45.2%)
and to 106 in the non-exposed group (25.2%; p Z 0.015).
After adjusting by GA and BW, only EONS and cPVL
remained significantly associated with exposure to clinical
chorioamnionitis (Table 3). In a post hoc analysis, we
searched for potential perinatal factors influencing the
development of cPVL. We included maternal chorioamnio-
nitis, the use of antenatal steroids, type of delivery, sex,
multiple gestation, Apgar score, need for advanced CPR,
and admission temperature. As a result of multiple
regression analysis, only chorioamnionitis was as an inde-
pendent factor for cPVL (ARRZ 28.4; 95% CIZ 2.5e322.4;
p Z 0.007).
Four patients in the group with chorioamnionitis devel-
oped EONS, two due to group B streptococcus and two by
Escherichia coli. Three patients in this group had an
episode of LONS, one by Staphylococcus epidermidis, one
by Klebsiella pneumoniae, and one by Candida albicans.
Among non-exposed infants, eight presented EONS, four
by E. coli, two by group B streptococcus, one by K. pneu-
moniae, and one by Enterococcus faecalis. LONS was mainly
due to Staphylococcus epidermidis accounting for 42 epi-
sodes, and “other bacteria” for 33 episodes. Only one pa-
tient in this group exhibited a late infection by C. albicans.
Fourteen patients in this group had more than one episode
of LONS.
The overall mortality among the VLBW infants was 9.5%.
Interestingly, mortality in the first 12 hours was significantly
higher in infants who were exposed to maternal cho-
rioamnionitis, but total mortality during hospital stay was
similar in both groups (12.9% vs. 9.3%; pZ 0.508). Likewise,
no differences were found in survival without major
morbidity among groups (Table 2).
In-hospital stay in survivors was longer in the cho-
rioamnionitis group (65.6  24.2 days) than in the non-
exposed group (53.4  26.5 days; p Z 0.021), but this
difference disappeared after adjusting by GA and BW in the
linear regression analysis (p Z 0.71). Time to death was
shorter in the first group (7.8  4.0 vs. 23.6  32.7 days),
but again without significant differences (p Z 0.344).4. Discussion
Maternal chorioamnionitis and intrauterine inflammation
are recognized risk factors for preterm birth, being impli-
cated in as many as 25e40% of cases,13,14 with a higher
incidence at the lowest GA.15 The diagnosis may be estab-
lished antepartum on the basis of clinical findings, as
Table 2 Univariate comparison of morbidity and mortality
between infants who were and were not exposed to
maternal clinical chorioamnionitis.
Variables Clinical
chorioamnionitis
(n Z 31)
Absence of
maternal
chorioamnionitis
(n Z 420)
p
RDS 61.3 37.6 0.009
PDA 45.2 32.1 0.137
EONS 12.9 1.9 <0.001
LONS 10.0 15.1 0.448
NEC 6.5 4.3 0.572
NEC surgery 6.7 1.7 0.06
Severe IVH 13.3 5.2 0.064
cPVL 6.7 0.2 <0.001
BPD 13.6 13 0.935
ROP (>2 stage) 16.7 7.5 0.122
Mortality in
first 12 h
3.2 0.2 0.016
Global mortality 12.9 9.3 0.508
Survival without
major
morbidity*
64.5 77.1 0.111
Data are presented as %.
BPD Z bronchopulmonary dysplasia; cPVL Z cystic periven-
tricular leukomalacia; EONS Z early-onset neonatal sepsis;
IVH Z intraventricular hemorrhage; LONS Z late-onset
neonatal sepsis; NECZ necrotizing enterocolitis; PDAZ patent
ductus arteriosus; RDS Z respiratory distress syndrome;
ROP Z retinopathy of prematurity.
* Survival without IVH Grades 3 or 4, cPVL, BPD, NEC, or ROP
>2 stage.
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ical. By contrast, cultures of amniotic fluid may not be
appropriate to detect some pathogens such as ureaplasma,
and the determination of molecular mediators ofTable 3 Comparison of outcomes between infants
exposed and not exposed to maternal clinical cho-
rioamnionitis after adjusting by gestational age and birth
weight.
Outcome ARR 95% CI p
RDS 1.451 0.620e3.395 0.391
PDA 0.919 0.399e2.120 0.844
EONS 6.132 1.665e22.582 0.006
LONS 0.366 0.102e1.317 0.124
NEC 0.940 0.197e4.478 0.938
Severe IVH 1.844 0.541e6.289 0.328
cPVL 24.619 1.869e324.277 0.015
BPD 0.558 0.142e2.183 0.402
ROP (>2 stage) 1.547 0.375e6.380 0.546
ARR Z adjusted relative risk; BPD Z bronchopulmonary
dysplasia; cPVL Z cystic periventricular leukomalacia;
EONS Z early-onset neonatal sepsis; IVH Z intraventricular
hemorrhage; LONS Z late-onset neonatal sepsis;
NEC Z necrotizing enterocolitis; PDA Z patent ductus arte-
riosus; RDSZ respiratory distress syndrome; ROPZ retinopathy
of prematurity.inflammation may be expensive and time-consuming.
Furthermore, histological chorioamnionitis is a postnatal
diagnosis that does not always correlate with clinical find-
ings, it is susceptible to variability in interpretation, and a
lack of reproducibility among pathologists has been
described.16 For these reasons, and from a practical point
of view, we chose the clinical definition of chorioamnionitis
in the present study.
The main findings of our study are the inverse correla-
tion of maternal chorioamnionitis with GA at birth
(Figure 1), and its association with EONS and cPVL. Other
outcomes, such as neonatal depression, need for advanced
resuscitation, RDS, and the need for surfactant therapy,
were not associated with clinical chorioamnionitis after
adjusting by GA and BW, in contrast to other studies.
A common limitation of some cohort studies could be the
lack of power to identify GA and BW as confounders or risk
modifiers. However, in a recent large multicenter study,
Soraisham et al17 found that clinical chorioamnionitis was
independently associated with EONS and severe IVH, but not
with PVL, and that this associationwas notmediated through
increased illness severity. In our study, severe IVH was more
frequent in exposed infants (13.3% vs. 5.2%), but this lacked
statistical significance (Tables 2 and 3). Results in the liter-
ature are still controversial. Some studies found both severe
IVH and PVL to be higher in infants born to mothers with
clinical chorioamnionitis.18 In a study by Verma et al19,
however, clinical but not histological chorioamnionitis was
associated with severe abnormal cerebral scans. This lack of
correlation between clinical chorioamnionitis and brain
damage was also found by Sarkar et al.20 Nevertheless, a
meta-analysis by Wu et al,21 although referring to term and
near-term newborns, showed that clinical chorioamnionitis
increases the risk of cPVL and cerebral palsy (CP). It is likely
that the variability in the criteria used to define cho-
rioamnionitis, along with the lack of a normal control group,
makes it difficult to compare outcomes.7 In addition, most
studies included only cases of cPVL, which is now estimated
to constitute <10% of all cases of white matter damage
(WMD). A prospective study of 100 preterm infants studied at
the age of termwithmagnetic resonance imaging (MRI) found
a high incidence of cerebral whitematter abnormality, in the
form of non-cystic injury. The major perinatal risk factors
were related to perinatal infection, particularly maternal
fever and infant sepsis.22
In fact, infection seems to be the only pathological
process with a widely recognized causal link with prema-
turity and a defined molecular pathophysiology.23 Although
it remains a controversial area, there is also an important
body of knowledge about the etiology of WMD in the brain
of the fetus and newborn, with two main factors impli-
cated, ischemia and inflammation, in addition to the high
vulnerability of oligodendroglia to oxidative stress. The
anatomical characteristics of the cerebral vascularization
in the preterm infant,24 with scarce anastomosis between
vessels and common watershed areas, together with an
immature cerebral blood flow autoregulation, renders the
brain prone to focal or diffuse nervous tissue damage in
situations which are frequently found in the critically ill
neonate, such as hypotension, hypocarbia, PDA, etc.25
Inflammation can be secondary to both infection and
ischemia, and it is an important mechanism of damage or
Chorioamnionitis and morbimortality in VLBW infants 385death of oligodendroglial precursors,26 mediated by proin-
flammatory cytokines, mainly interferon-g and tumor ne-
crosis factor-a,27 and through the activation of microglia
and free radical production in the immature cerebral white
matter.28 It is important to emphasize that the different
mechanisms of WMD frequently interact, and hypo-
xiaeischemia itself could initiate the inflammatory cascade
in the absence of microbial organisms,29 although the levels
of cytokines are higher if an infection is present.27 The
potentiation of both mechanisms has been highlighted in
animal studies.30 All these factors can contribute to cere-
bral WMD before, during, and/or after birth during the
postnatal period. As mentioned previously, many epidemi-
ological studies have shown an association between peri-
natal systemic inflammation in the fetus or newborn and
the development of PVL with its potential future
repercussions.21,31e35 It is estimated that 1.5% of VLBW
infants will present an EONS and around 21% a LONS,36 with
a higher incidence in the most immature infants. A recent
multicenter study has shown that confirmed bacterial sepsis
independently increases the risk of CP [odds ratio
(OR) Z 2.9; 95% CI Z 1.22e6.89; p Z 0.016] and neuro-
developmental impairment (OR Z 1.86; 95%
CI Z 1.12e3.05; p Z 0.016), defined as a Mental or Psy-
chomotor Developmental Index lower than 70, CP, and/or
visual or auditory impairment.37
As stated previously, in our study the incidence of EONS,
but not LONS, was significantly higher among infants
exposed to maternal clinical chorioamnionitis (Table 2),
and this correlation persisted after adjusting by GA and BW
(Table 3). Taking into account the connection between
perinatal infection and cerebral WMD, we studied the
possible relationship between proven bacterial infection
and cPVL among our patients, independently of exposure to
maternal chorioamnionitis. A total of 74 infants (16.4%) had
at least one episode of perinatal infection (early or late).
Although the incidence of cPVL was higher among infants
with at least one episode of perinatal bacterial infection
(1.4% vs. 0.5%), this difference was not significant
(p Z 0.433). It is likely that our study was not powered
enough to unravel a possible association. Furthermore, we
used cranial ultrasonography, which has a low sensitivity for
detection of non-cystic WMD in contrast to MRI or neuro-
pathological analysis.
In conclusion, our results support the previous evidence
that the incidence of maternal clinical chorioamnionitis
correlates inversely with GA. VLBW infants born to mothers
with this condition in our area have a higher risk of EONS,
which is independent of GA and BW. Our results also suggest
a probable association between prenatal exposure to clin-
ical chorioamnionitis and the development of cPVL in the
postnatal period.
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